Associated Banc-Corp’s GSK GSK Stock Holding History

Associated Banc-Corp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,352	Closed	-$206K	–	333
2024 Q2	$206K	Buy	+5,352	New	+$225K	0.01%	305
2021 Q1	–	Sell	-59	Closed	-$3K	–	542
2020 Q4	$3K	Sell	59 -23	-28%	-$1.06K	﹤0.01%	637
2020 Q3	$4K	Sell	82 -20	-20%	-$1K	﹤0.01%	477
2020 Q2	$5K	Sell	102 -88	-46%	-$4.51K	﹤0.01%	430
2020 Q1	$9K	Buy	+190	New	+$10.1K	﹤0.01%	400
2017 Q3	–	Sell	-4,165	Closed	-$224K	–	281
2017 Q2	$224K	Hold	4,165	–	–	0.01%	261
2017 Q1	$220K	Buy	+4,165	New	+$211K	0.01%	263
2015 Q3	–	Sell	-3,889	Closed	-$203K	–	280
2015 Q2	$203K	Buy	3,889 +112	+3%	+$6.31K	0.01%	271
2015 Q1	$218K	Buy	+3,777	New	+$217K	0.01%	266
2013 Q3	–	Sell	-5,989	Closed	-$374K	–	253
2013 Q2	$374K	Buy	+5,989	New	+$380K	0.03%	197

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Associated Banc-Corp's GSK Position: Q3 2024 in Review

Associated Banc-Corp sold out of GSK (GSK) in Q3 2024, closing a stake of 5,352 shares — an estimated $206K sold.

Associated Banc-Corp first reported a position in GSK in Q2 2013 and held it in 10 quarters. The position peaked at $374K in Q2 2013. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

Associated Banc-Corp reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
Associated Banc-Corp sold 5,352 GSK shares in Q3 2024, an estimated $206K.
Associated Banc-Corp first reported a position in GSK in Q2 2013 and held it in 10 quarters.
Associated Banc-Corp's GSK position peaked at $374K in Q2 2013.
899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Associated Banc-Corp's 13F filing for Q3 2024, filed 13 Nov 2024.